title: Cabergoline plus lanreotide for ectopic Cushing's syndrome.
authors.forename: Rosario
authors.initials: R
authors.lastname: Pivonello
authors.forename: Diego
authors.initials: D
authors.lastname: Ferone
authors.forename: Steven W J
authors.initials: SW
authors.lastname: Lamberts
authors.forename: Annamaria
authors.initials: A
authors.lastname: Colao
mesh_terms: D000182:ACTH Syndrome, Ectopic / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D000077465:Cabergoline; D002276:Carcinoid Tumor / Q000601:surgery; D003480:Cushing Syndrome / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D004873:Ergolines; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D000077465:Cabergoline